Onderneming 4d Pharma PLC London S.E.
Aandelen
GB00BJL5BR07
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 53 | 18-02-14 | |
Duncan Peyton
FOU | Founder | 54 | 18-01-14 |
Imke Mulder
CTO | Chief Tech/Sci/R&D Officer | - | - |
Corporate Officer/Principal | - | - | |
Richard Avison
PRN | Corporate Officer/Principal | - | - |
Glenn Dourado
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Maier
BRD | Director/Board Member | 76 | 01-03-21 |
Director/Board Member | 64 | 08-09-19 | |
Duncan Peyton
FOU | Founder | 54 | 18-01-14 |
Founder | 53 | 18-02-14 | |
Katrin Rupalla
BRD | Director/Board Member | 56 | 23-09-20 |
Alexander Macrae
BRD | Director/Board Member | 61 | 27-08-19 |
Chairman | 64 | 08-01-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 180 337 577 | 143 586 109 ( 79,62 %) | 0 | 79,62 % |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
4D Pharma León SLU
4D Pharma León SLU Pharmaceuticals: MajorHealth Technology Part of BacThera AG, 4D Pharma León SLU is a pharmaceutical company based in León, ES. 4D Pharma León SLU was acquired by BacThera AG from 4D Pharma Plc on March 13, 2023. The Spanish company manufactures pharmaceutical products. |
Pharmaceuticals: Major
|
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,66% | 111 mld. | |
+11,23% | 105 mld. | |
-0,38% | 21,93 mld. | |
-12,15% | 22,34 mld. | |
-7,66% | 18,59 mld. | |
-36,52% | 18,12 mld. | |
-10,09% | 16,96 mld. | |
+3,33% | 13,7 mld. | |
+36,58% | 12,45 mld. |